RNA nucleic acid for enhancing lung cancer radiotherapy sensitivity
A sensitive, nucleic acid technology, applied in the fields of molecular biology and genetic diagnostics, which can solve the role of miR-320a. Few studies, few, and no evidence that miR-320a enhances radiation resistance and sensitivity of lung adenocarcinoma to radiation response And other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] Taking the designed miR-320a nucleic acid as an example, it shows that it significantly increases the sensitivity of radiation-resistant lung adenocarcinoma cells to radiotherapy, and improves the application of killing tumor cells.
[0017] 1. Required materials
[0018] A549 cells (Shanghai Institute of Cell Biology); A549 / R34 cells (A549 cells were obtained by accumulatively irradiating 68Gy with X-ray); RPMI-1640 medium (Gibco, Grand Island, New York, U.S.A.); fetal bovine serum (FBS, Gibco); Annexin V-FITC / PI (KeyGEN Biotech. Co. Ltd., Nanjing, China); MTT (0.5 mg / ml); Liposome 2000 (Invitrogen, Carlsbad, CA, USA).
[0019] 2. Cell culture and transfection
[0020] Lung adenocarcinoma A549 cells were cultured in 10% FBS RPMI-1640 medium at 37°C in an incubator with 5% CO2, and the cells were irradiated with 2Gy X-ray each time, once every 2 days, for a total of 34 times , with a total dose of 68Gy, to establish a radiation-resistant lung adenocarcinoma cell line ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com